Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2022.3679
Abstract: Importance Anxiety disorders are common, highly distressing, and impairing conditions. Effective treatments exist, but many patients do not access or respond to them. Mindfulness-based interventions, such as mindfulness-based stress reduction (MBSR) are popular and can… read more here.
Keywords: anxiety disorders; trial; mindfulness based; escitalopram ... See more keywords
Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data
Sign Up to like & getrecommendations! Published in 2022 at "European Archives of Psychiatry and Clinical Neuroscience"
DOI: 10.1007/s00406-022-01392-x
Abstract: Dear Doctor Letters (DDLs, Direct Healthcare Professional Communications) from 2011 provided guidance regarding QTc-prolonging effects with risk of torsade de pointes during treatment with citalopram and escitalopram. This study examines the DDLs’ effects on prescription… read more here.
Keywords: dear doctor; citalopram escitalopram; doctor letters; escitalopram ... See more keywords
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
Sign Up to like & getrecommendations! Published in 2023 at "Psychological medicine"
DOI: 10.1017/s0033291723001514
Abstract: BACKGROUND Psilocybin Therapy (PT) is being increasingly studied as a psychiatric intervention. Personality relates to mental health and can be used to probe the nature of PT's therapeutic action. METHODS In a phase 2, double-blind,… read more here.
Keywords: personality; escitalopram; trial; psilocybin therapy ... See more keywords
Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram.
Sign Up to like & getrecommendations! Published in 2022 at "ACS chemical neuroscience"
DOI: 10.1021/acschemneuro.1c00694
Abstract: Human serotine transporter (hSERT) is one of the most influential drug targets, and its allosteric modulators (e.g., escitalopram) have emerged to be the next-generation medication for psychiatric disorders. However, the molecular mechanism underlying the allosteric… read more here.
Keywords: molecular mechanism; transporter; escitalopram; hsert ... See more keywords
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacopsychiatry"
DOI: 10.1055/a-2039-2829
Abstract: Abstract Introduction Cross sectional therapeutic drug monitoring (TDM) data mining introduces new opportunities for the investigation of medication treatment effects to find optimal therapeutic windows. Medication discontinuation has been proven useful as an objective surrogate… read more here.
Keywords: treatment effects; escitalopram; treatment failure; treatment ... See more keywords
Spontaneous alternation and stereotypical behaviour in deer mice: response to escitalopram and levetiracetam
Sign Up to like & getrecommendations! Published in 2022 at "Behavioural Pharmacology"
DOI: 10.1097/fbp.0000000000000678
Abstract: Obsessive-compulsive disorder is varyingly associated with cognitive impairment, that is, deficits in spatial working memory, although it seems unlikely that this is generalised across all domains of functioning. Further, it is unclear whether symptoms will… read more here.
Keywords: alternation; escitalopram; behaviour; deer mice ... See more keywords
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14278
Abstract: Escitalopram (SCIT) is frequently prescribed to breastfeeding women. Available information on SCIT excretion into breast milk is based on heterogeneous and incomplete data. A population pharmacokinetic model that aimed to better characterize maternal and infant… read more here.
Keywords: population pharmacokinetic; pharmacokinetic model; breast milk; escitalopram ... See more keywords
Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan
Sign Up to like & getrecommendations! Published in 2017 at "BMJ Case Reports"
DOI: 10.1136/bcr-2017-221486
Abstract: A 63-year-old woman with a history of long-standing depression, maintained on escitalopram, presented with altered mental status. Patient had recently been prescribed dextromethorphan-promethazine cough syrup 2 weeks prior for an upper respiratory tract infection. On admission,… read more here.
Keywords: caused drug; syndrome caused; serotonin syndrome; drug ... See more keywords
The combination of escitalopram and aripiprazole: Investigation of psychomotor effects in rats
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Psychopharmacology"
DOI: 10.1177/0269881117732515
Abstract: Pre-clinical and clinical evidence suggests that the antidepressant efficacy of the selective serotonin reuptake inhibitor escitalopram can be enhanced by the dopamine and serotonin partial agonist aripiprazole. Given the range of possible neurochemical interactions between… read more here.
Keywords: psychomotor effects; escitalopram aripiprazole; escitalopram; psychomotor ... See more keywords
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Psychopharmacology"
DOI: 10.1177/02698811221095832
Abstract: Background: Antidepressant use for major depressive disorder (MDD) is frequently associated with sexual dysfunction. Aims: Cross-sectional and longitudinal relationships between antidepressant treatment outcomes and sexual functioning (SF) were evaluated separately for males and females receiving… read more here.
Keywords: sexual functioning; escitalopram; treatment; response ... See more keywords
Escitalopram-induced hepatitis: A case report
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i8.2468
Abstract: BACKGROUND The antidepressant escitalopram is widely prescribed for the treatment of depression. It is generally well-tolerated, and cholestasis is not mentioned in its summary of product characteristics (SmPC). We present a case of cholestatic and… read more here.
Keywords: case; cholestasis; escitalopram; hepatitis ... See more keywords